PSA velocity and prostate cancer [3] (multiple letters)

New England Journal of Medicine

Volumn 351, Issue 17, 2004, Pages 1800-1802

  Dodd, Lori E ^a   Simon, Richard ^a   Bianco Jr , Fernando J ^b   Kattan, Michael W ^b   Scardino, Peter T ^b   D'Amico, Anthony V ^c   Chen, Ming Hui ^d   Catalona, William J ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CONNECTICUT   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; ANTIGEN DETECTION; CANCER RECURRENCE; HUMAN; INTERMETHOD COMPARISON; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN VELOCITY; RISK FACTOR; STATISTICAL ANALYSIS; VALIDATION PROCESS; BLOOD; MALE; MULTIVARIATE ANALYSIS; NOTE; PROSTATE TUMOR; RISK; ADJUVANT CHEMOTHERAPY; DISEASE FREE SURVIVAL; PROSTATECTOMY; TUMOR RECURRENCE;

HUMANS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY;

EID: 19544383757     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200410213511723     Document Type: Letter

References (0)